Module 1: Commitment to DEI
Commitment to DEI describes the grounds for institutional and individual commitment to diversity, equity, and inclusion in clinical research, and illustrates how to substantiate commitment with actions, metrics, and resources.
Original Release Date: July 15, 2022
Expiration Date: August 15, 2024
Review Date: August 10, 2023 by Willyanne Decormier Plosky, DrPH
This activity is intended for leadership, investigators, practicing providers, clinical trialists, clinical trials staff, nurse practitioners, nurses, research nurse specialists, physician assistants, clinical research coordinators, other frontline staff, regulatory and IRB committee members, and others who design, conduct, report, or are responsible for clinical research.
Upon completion of this activity, participants will be able to:
- Appreciate background and context of DEI
- Understand importance of institutional commitment to DEI in clinical research
- Substantiate a statement of commitment
- Identify roles of members of the clinical research community to support commitments with actions and resources
- Consider measures to evaluate progress on institutional commitment to DEI in clinical research
PLEASE NOTE: For questions or assistance with any special needs regarding the training course, please contact the MRCT Center at: MRCT@bwh.harvard.edu
YOU MAY ALSO BE INTERESTED IN Interpretation and Application of ICH E6(R2)
Welcome to Version 1.0 of Interpretation and Application of ICH E6(R2) – an online course developed by the MRCT Center with a multi-stakeholder international team of experts.
Many thanks to the following people for acting as discussants during this training series:
Ms. LaShell Robinson, Director for Diversity & Inclusion in Clinical Trials, Takeda Pharmaceuticals
Dr. Ravi Thadhani, Chief Academic Officer, Mass General Brigham; Professor of Medicine and Academic Dean, Harvard Medical School
This activity is not for credit.